
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
FOR IMMEDIATE RELEASE
3 July 2025
RECOMMENDED CASH AND SHARE OFFER
FOR DIRECT LINE INSURANCE GROUP PLC ("Direct line")
BY AVIVA PLC ("AVIVA")
to be effected by means of a Scheme of Arrangement
under Part 26 of the Companies Act 2006
Aviva is pleased to confirm that 378,143,305 new ordinary shares of 32 17/19 pence each in the capital of Aviva (the "New Aviva Shares") were admitted to listing on the Official List maintained by the Financial Conduct Authority (the "FCA") and to trading on the London Stock Exchange's main market for listed securities, with effect from 8.00 a.m. today, 3 July 2025.
Following the admission of the New Aviva Shares and in accordance with the FCA's Disclosure Guidance and Transparency Rules 5.6.1R and 5.6.1AR, Aviva hereby notifies the market that Aviva's issued share capital as at today, 3 July 2025, consists of 3,057,000,059 ordinary shares of 32 17/19 pence each. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Aviva under the FCA's Disclosure Guidance and Transparency Rules.
Capitalised terms used but not otherwise defined in this announcement have the meanings given to them in the scheme document published on 10 February 2025 in relation to the Acquisition.
Enquiries |
|
|
|
Aviva |
|
Media |
|
Andrew Reid |
+44 (0)7800 694 276 |
Sarah Swailes |
+44 (0)7800 694 859 |
Investors and analysts |
|
Greg Neilson |
+44 (0)7800 694 564 |
Joel von Sternberg |
+44 (0)7384 231 238 |
Michael O'Hara |
+44 (0)7387 234 388 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.